APRE - Aprea Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APRE is currently covered by 2 analysts with an average price target of $15.64. This is a potential upside of $13.8 (750%) from yesterday's end of day stock price of $1.84.

Aprea Therapeutics's activity chart (see below) currently has 14 price targets and 23 ratings on display. The stock rating distribution of APRE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 18.57 days.

Highest price target for APRE is $11, Lowest price target is $11, average price target is $11.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 15-Jan-2025. First documented stock forecast 28-Oct-2019.

Currently out of the existing stock ratings of APRE, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4 months 30 days ago
(15-Jan-2025)

0/6 (0%)

$15.86 (383.09%)

Buy

$11

$9.16 (497.83%)

$11

10 months 1 days ago
(13-Aug-2024)

0/3 (0%)

$7.7 (233.33%)

Hold

$80

$78.16 (4247.83%)

3 years 2 months 29 days ago
(16-Mar-2022)

1/4 (25%)

$40.2 (101.01%)

44

Hold

$40

$36.17 (944.39%)

$80

3 years 2 months 29 days ago
(16-Mar-2022)

3/4 (75%)

$0.2 (0.50%)

21

Sell

$500

3 years 9 months 25 days ago
(20-Aug-2021)

1/1 (100%)

$47.6 (10.52%)

2

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APRE (Aprea Therapeutics) average time for price targets to be met?

On average it took 18.57 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on APRE (Aprea Therapeutics) with a proven track record?

JEFFREY HUNG

Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?

Jeffrey Hung works at MORGAN STANLEY and has 6 price targets and 7 ratings on APRE

Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?

Gregory Renza with highest potential upside - $78.16

Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?